A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts
A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts
通过四位分析师的专家观点，深入了解health catalyst。
In the last three months, 4 analysts have published ratings on Health Catalyst (NASDAQ:HCAT), offering a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有4位分析师公布了对Health Catalyst（纳斯达克股票代码：HCAT）的评级，提供了从看涨到看跌的不同视角。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Health Catalyst, revealing an average target of $11.5, a high estimate of $14.00, and a low estimate of $8.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 6.12%.
分析师已经为Health Catalyst设定了12个月的目标股价，显示平均目标股价为11.5美元，最高估计为14.00美元，低估值为8.00美元。随着分析师将平均目标股价下调了6.12％，情绪的负面转变显而易见。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：仔细观察
In examining recent analyst actions, we gain...
在研究分析师最...
登录免费看全文
登录/注册